Prepared by R.R. Donnelley Financial -- Form 8-K

0001021408-02-009609.txt : 20020719 0001021408-02-009609.hdr.sgml : 20020719 20020719111631 ACCESSION NUMBER: 0001021408-02-009609 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020715 ITEM INFORMATION: Changes in registrant's certifying accountant ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 02706286 BUSINESS ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 BUSINESS PHONE: 5032833911 MAIL ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Prepared by R.R. Donnelley Financial -- Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 15, 2002

OXIS INTERNATIONAL, INC.

(Exact name of Registrant as specified in its charter)

Delaware		0-8092		94-1620407
(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification No.)

6040 N. Cutter Circle, Suite 317, Portland, Oregon 97217

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (503) 283-3911

Not applicable

(Former name or former address, if changed since last report)

Item 4. Changes in Registrant’s Certifying Accountant.

(a) Effective July 15, 2002, OXIS International, Inc. (“OXIS”) dismissed its prior independent accountant, King Griffin & Adamson P.C. (“KGA”). As part of OXIS’ ongoing efforts to reduce expenses, the Audit Committee of the Board of Directors recommended to the full Board that OXIS make a further change in accountants in order to establish a relationship with principal accountants in closer proximity to Portland, Oregon. The Board of Directors accepted the recommendation. OXIS previously reported to the Securities and Exchange Commission (“SEC”) on January 18, 2002, on Form 8-K a change in its principal accountants, from Deloitte & Touche LLP (“Deloitte”) to KGA effective for the fiscal year ending December 31, 2001.

KGA’s independent auditors’ report dated February 22, 2002, except for Note 9, for which the date is March 1, 2002, on OXIS’ consolidated financial statements as of and for the year ended December 31, 2001, and Deloitte’s independent auditor’s report dated March 1, 2001, on OXIS’ consolidated financial statements as of and for the year ended December 31, 2000, appearing in OXIS’ Annual Report of Form 10-KSB for the year ended December 31, 2001 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles except for an explanatory paragraph relating to OXIS’ ability to continue as a going concern.

During the audits of OXIS’ consolidated financial statements as of and for the years ended December 31, 2001 and 2000, and through the subsequent interim period to the date hereof, there were no disagreements between OXIS, KGA and Deloitte on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of KGA or Deloitte, would have caused either to make a reference to the subject matter of the disagreements in connection with its reports.

OXIS has requested that KGA furnish it with a letter addressed to the SEC stating whether or not it agrees with the above statements. A copy of such letter is being filed as Exhibit 16 to this Form 8-K.

(b) Also, effective July 15, 2002, OXIS engaged Williams & Webster, P.S. as its principal accountant to audit the OXIS financial statements. During the last two fiscal years and the subsequent interim period to the date hereof, OXIS did not consult Williams & Webster, P.S. regarding any of the matters or events set forth in Item 304 (a) (2) (i) and (ii) of Regulation S-K.

Item 7. Financial Statements, Proforma Financial Information and Exhibits.

The following exhibits are filed herewith:

16. Letter addressed to OXIS dated July 19 2002, from King Griffin & Adamson P.C. to the Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OXIS INTERNATIONAL, INC. (Registrant)

By:		/s/ SHARON ELLIS
		Sharon Ellis Chief Operating and Financial Officer

Date: July 19, 2002

EXHIBIT INDEX

Exhibit Number		Description

16.		Letter addressed to OXIS International, Inc. dated July 19, 2002, from King Griffin & Adamson P.C. to the Securities and Exchange Commission.

EX-16 3 dex16.htm LETTER ADDRESSED TO OXIS INTERNATIONAL, INC. Prepared by R.R. Donnelley Financial -- Letter addressed to Oxis International, Inc.

Exhibit 16

July 19, 2002

Securities and Exchange Commission

450 5th Street N.W.

Washington, D.C. 20549

RE: OXIS INTERNATIONAL, INC.

We have read Item 4 of the Form 8-K of OXIS International, Inc. dated July 19, 2002, and agree with such statements made concerning our firm contained therein. We have no basis to agree or disagree with other statements made under Item 4.

Very truly yours,

/s/ KING GRIFFIN & ADAMSON P.C.